Health Condition 1: D093- Carcinoma in situ of thyroid and other endocrine glands
Conditions
Interventions
Intervention1: NIL: Not applicable
Intervention2: NIL: NIL
Control Intervention1: NIL: No such molecule is currently available globally, this ready to use formulation seems very promising. 68Ga-mDesmo
Sponsors
Biomedical Device and Technology Development BDTD DST India
B J Madan Co
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with endogenous Cushing’s syndrome 2.Patients in the age group of 5 to 75 years. 3.Patients willing to give consent.
Exclusion criteria
Exclusion criteria: 1.Patient with exogenous exposure to steroids 2.Ongoing pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PET/CT imaging to provide functional as well as anatomical information for intra-operative tumor navigation and preservation of normal pituitary.Timepoint: Single time point. | — |
Secondary
| Measure | Time frame |
|---|---|
| Diagnostic outcome will benefit in precision surgery of pitutiary micro-adenomaTimepoint: Single point | — |
Countries
India
Contacts
Public ContactDr Rama Walia
Post Graduate Institute of Medical Education and Research, Chandigarh
Outcome results
None listed